The findings demonstrate that aprocitentan may help reduce the risk of kidney disease progression, cardiovascular events, and ...

An analysis of 25 years of the CDC WONDER database for death rates from hypertension-related kidney disease (also called hypertensive kidney disease or hypertensive renal disease) in the U.S. through ...

Mineralys Therapeutics' experimental drug significantly reduced blood pressure in patients with chronic kidney disease, according to new data presented at a major European medical ​conference on ...

Please provide your email address to receive an email when new articles are posted on . Deaths from hypertensive renal disease rose during the past 25 years in the U.S. Men, Black individuals and ...

The United States death rate from high blood pressure-related kidney disease experienced a 48% jump over the last 25 years, according to preliminary research presented at the American Heart ...

A research team from the Medical University of Vienna has investigated structural changes in kidneys of patients with hypertension and type 2 diabetes. The results show that high blood pressure can ...

Hypertensive kidney disease arises from the sustained elevation of systemic blood pressure and involves a convergence of haemodynamic, inflammatory and metabolic pathways that culminate in progressive ...

The death rate from hypertensive kidney disease (high blood pressure-related kidney disease) increased by 48% in the U.S. over the past 25 years, with continued differences across demographic groups, ...

Lorundrostat led to significant reductions in systolic blood pressure and UACR in CKD patients. Adverse events were low, with 3% discontinuing during lorundrostat vs. 2% on placebo. A new wave of ...

The death rate from hypertensive kidney disease (high blood pressure-related kidney disease) increased by 48% in the U.S. over the past 25 years, with continued differences across demographic groups, ...